Clinical Trials Arena December 6, 2024
Sentiment towards digital and AI tech in the clinical research sector remains positive, with “slow and steady” uptake.
A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector is positive, with 49% of pharmaceutical and biotechnology companies employing AI and Big Data in their programs. This represents a 10% increase from the number recorded in ICON’s 2019 survey.
ICON has published the results in its new whitepaper –Digital disruption: Surveying the industry’s evolving landscape – looking to understand the trajectory of artificial intelligence (AI) and digital research within the clinical research field.
A total of 101 responses from biotech and pharmaceutical professionals across Europe and North America were considered.
The...
Today's Sponsors
Today's Sponsor